EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression

Muneeba Jilani, David Degras iD, Nurit Haspel

Genes · 2024

DOI: 10.3390/genes15050631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Muneeba Jilani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, University of Massachusetts Boston, Boston, MA 02125, USA. Hauptthemen laut MEDLINE: DNA Methylation, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advancements in the field of next generation sequencing (NGS) have generated vast amounts of data for the same set of subjects. The challenge that arises is how to combine and reconcile results from different omics studies, such as epigenome and transcriptome, to improve the classification of disease subtypes. In this study, we introduce sCClust (sparse canonical correlation analysis with clustering), a technique to combine high-dimensional omics data using sparse canonical correlation analysis (sCCA), such that the correlation between datasets is maximized. This stage is followed by clustering the integrated data in a lower-dimensional space. We apply sCClust to gene expression and DNA methylation data for three cancer genomics datasets from the Cancer Genome Atlas (TCGA) to distinguish between underlying subtypes. We evaluate the identified subtypes using Kaplan–Meier plots and hazard ratio analysis on the three types of cancer—GBM (glioblastoma multiform), lung cancer and colon cancer. Comparison with subtypes identified by both single- and multi-omics studies implies improved clinical association. We also perform pathway over-representation analysis in order to identify up-regulated and down-regulated genes as tentative drug targets. The main goal of the paper is twofold: the integration of epigenomic and transcriptomic datasets followed by elucidating subtypes in the latent space. The significance of this study lies in the enhanced categorization of cancer data, which is crucial to precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationGene Expression Regulation, NeoplasticHumansLung NeoplasmsNeoplasmsTranscriptomeGlioblastomaColonic NeoplasmsGene Expression ProfilingHigh-Throughput Nucleotide SequencingCluster AnalysisBiomarkers, Tumor

Stichwörter der Autor:innen

cancer subtypesdata integrationmulti-omics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Computer Science, University of Massachusetts Boston, Boston, MA 02125, USA.
  • Department of Mathematics, University of Massachusetts Boston, Boston, MA 02125, USA.

ORCID-Profile: David Degras

Zitieren

APA

Jilani, M., Degras, D., & Haspel, N. (2024). Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression. Genes. https://doi.org/10.3390/genes15050631

Vancouver

Jilani M, Degras D, Haspel N. Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression. Genes. 2024. doi:10.3390/genes15050631

BibTeX
@article{Jilani2024,
  author = {Jilani, Muneeba and Degras, David and Haspel, Nurit},
  title = {Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15050631}
}
Kostenlos starten →